(Q35398592)

8 August 2017

Predictive value of topoisomerase II alpha immunostaining in urothelial bladder carcinoma (English)

1 reference

8 August 2017

1 reference

Nakopoulou L

1

1 reference

8 August 2017

Zervas A

2

1 reference

8 August 2017

Lazaris AC

3

1 reference

8 August 2017

Constantinides C

4

1 reference

8 August 2017

Stravodimos C

5

1 reference

8 August 2017

Davaris P

6

1 reference

8 August 2017

Dimopoulos C

7

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Journal of Clinical Pathology

8 August 2017

1 reference

8 August 2017

54

1 reference

8 August 2017

4

1 reference

8 August 2017

309-313

1 reference

Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731402

Mutations of human topoisomerase II alpha affecting multidrug resistance and sensitivity.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731402

Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731402

BCL-2 family: regulators of cell death

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731402

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731402

Immunohistochemical staining for DNA topoisomerase II in non-Hodgkin's lymphomas

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731402

Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731402

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731402

Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor

26 September 2018

1 reference

12 December 2020

Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer

1 reference

12 December 2020

Physiological regulation of eukaryotic topoisomerase II

1 reference

12 December 2020

Induction of apoptosis by deregulated expression of DNA topoisomerase IIalpha

1 reference

12 December 2020

Topoisomerase II alpha expression in esophageal squamous cell carcinoma

1 reference

12 December 2020

Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications

1 reference

12 December 2020

Elevations of DNA topoisomerase I in transitional cell carcinoma of the urinary bladder: correlation with DNA topoisomerase II-alpha and p53 expression

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.54.4.309

1 reference

8 August 2017

1 reference

8 August 2017

1 reference